Currently, there are 989.09M common shares owned by the public and among those 988.42M shares have been available to trade.
The company’s stock has a 5-day price change of -5.63% and 25.14% over the past three months. BKR shares are trading 20.57% year to date (YTD), with the 12-month market performance up to 27.82% higher. It has a 12-month low price of $28.32 and touched a high of $45.17 over the same period. BKR has an average intraday trading volume of 6.73 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -4.52%, 2.70%, and 16.91% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Baker Hughes Co (NASDAQ: BKR) shares accounts for 94.71% of the company’s 989.09M shares outstanding.
It has a market capitalization of $40.78B and a beta (3y monthly) value of 1.38. The stock’s trailing 12-month PE ratio is 18.45, while the earnings-per-share (ttm) stands at $2.23. The company has a PEG of 0.53 and a Quick Ratio of 0.88 with the debt-to-equity ratio at 0.37. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.66% over the week and 2.32% over the month.
Earnings per share for the fiscal year are expected to increase by 44.63%, and 11.61% over the next financial year. EPS should grow at an annualized rate of 34.58% over the next five years, compared to 33.59% over the past 5-year period.
Wells Fargo coverage for the Baker Hughes Co (BKR) stock in a research note released on September 25, 2024 offered a Overweight rating with a price target of $42. TD Cowen on their part issued Outperform rating on January 25, 2024.
